Belpointe Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-343
Closed -$21.9K 3019
2023
Q1
$21.9K Buy
343
+95
+38% +$6.2K ﹤0.01% 2261
2022
Q4
$12K Buy
+248
New +$15.6K ﹤0.01% 2515

Other funds holding STAA

Belpointe Asset Management's STAA Position: Q2 2023 in Review

Belpointe Asset Management sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 343 shares — an estimated $21.9K sold.

Belpointe Asset Management first reported a position in STAA in Q4 2022 and held it in 2 quarters. The position peaked at $21.9K in Q1 2023. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Belpointe Asset Management reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 343 STAAR Surgical shares in Q2 2023, an estimated $21.9K.
  • Belpointe Asset Management first reported a position in STAAR Surgical in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's STAAR Surgical position peaked at $21.9K in Q1 2023.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.